Fisher & Paykel Healthcare dodges worst of US tariff risk: Jarden

Fisher & Paykel Healthcare dodges worst of US tariff risk: Jarden
About 43% of Fisher & Paykel Healthcare’s revenue comes from the US. (Image: Supplied)
John Anthony
Jarden has raised its rating and target share price for Fisher & Paykel Healthcare by 10%, as Thursday’s US tariff announcements proved less damaging than expected.Following US President Donald Trump’s unveiling of “Liberation Day” tariffs, shares in Fisher & Paykel Healthcare (FPH), a company with significant export exposure to the US, traded as low as $32.60 in the wake of the announcement on Thursday. They were currently at $34.80.In a research note released late Thursday evening, Jarden analysts Adrian Allbon...

More Economy

Govt slashes Budget 2025 operating allowance
Economy

Govt slashes Budget 2025 operating allowance

Budget 2025 operating allowance is now $1.3 billion. 

Exporter eyes golden growth from revamped investor visa
Retail

Exporter eyes golden growth from revamped investor visa

Could a foreign investor be the solution to Anihana's quest for capital?

Consumer confidence back on the up – ANZ survey
Economy Free

Consumer confidence back on the up – ANZ survey

Consumer confidence rose five points to 98.3 in April, according to the latest ANZ-Roy Morgan survey, shoring up the upward trend that was starting to look wobbly.But inflation expectations also rose sharply – up 0.5 points to 4.7%, the highest reading since July 2023.“Household...

Staff reporters 24 Apr 2025
‘Uncertainty abounds’: Willis on trade war challenges
Economy

‘Uncertainty abounds’: Willis on trade war challenges

The impacts for NZ are twofold and will make its economic recovery harder, Willis says.

Rebecca Howard 23 Apr 2025